Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1994-12-20
1997-05-13
Kight, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514177, 514178, 514182, 514824, 536 5, A61K 31705, A61K 3156
Patent
active
056292953
DESCRIPTION:
BRIEF SUMMARY
BACKGROUND OF THE INVENTION
This invention relates to steroidal glycosides and methods of using the same, particularly as hypocholesterolemic agents and antiatherosclerosis agents, in mammals.
Many known products possessing hypocholesterolemic activity are cross-linked synthetic polymer derivatives, for example of polystyrene. For example, cross-linked, water-insoluble, bile-acid-binding polystyrene-based resins, e.g., Cholestyramine.RTM. agents, have a gritty "mouth-feel", and thus have poor palatability. In addition, these resin beads typically have a low in vivo efficiency. Thus, the effective hypocholesterolemic dose of these materials is excessive, typically 18-24 grams of formulated product per day. Other known polymers having hypocholesterolemic activity include the natural product chitosan and chitosan derivatives as described in European Application pub. no. 0212145. However, the effective hypocholesterolemic dose of these materials is also high.
Other known hypercholesterolemia controlling agents include plant extracts such as "alfalfa saponins". However, these plant extracts are of variable composition and contain significant amounts of nonuseful chemical substances. Due to the variations in composition, it is difficult to set a standard dosage or predict the impurities present. Thus, such extracts are not well suited for use by humans. Furthermore purification of these extracts would be expensive. As an alternative certain synthetically produced, pure "sapogenin-derived" compounds e.g., substances compounded from spirostane, spirostene or sterol-derived compounds depress cholesterol absorption more effectively than alfalfa extracts on a weight basis and thus can be administered in reasonable sized doses. Because the chemical compositions of these substances are known and because they can be synthesized at a high degree of purity, they are suitable for use by any warm-blooded animal, including humans.
However, unless administered in massive mounts, pure sapogenins do not significantly inhibit cholesterol's absorption. It is only when compounded with another moiety that sapogenins have the desired effect. Examples of such sapogenin compounds are compounds of tigogenin and diosgenin, particularly glycosides thereof. P. K. Kintia, Iu. K. Vasilenko, G. M. Godanu, V. A. Bobeiko, I. V. Suetina, N. E. Mashchenko, Kim. Pharm. Zh., 1981, 15(9), 55 discloses 3-O-(.beta.-D-galactopyranosyl)hecogenin and its use as a hypocholesterolemic agent. U.S. Pat. Nos. 4,602,003 and 4,602,005 disclose certain steroidal glycosides, in particular 3-O-(.beta.-D-glucopyranosyl)tigogenin and 3-O-(.beta.-D-cellobiosyl)tigogenin and their use for the control of hypercholesterolemia. 3-O-(.beta.-D-cellobiosyl)tigogenin has superior hypocholesterolemic activity when compared to, for example, cholestyramine.
In addition, certain other steroidal glycosides described below have been published, however these publications do not address hypocholesterolemic activity. "Structural Features of the Antioxidant and fungicidal Activity of Steroid Glycosides", Dimoglo, A. S.; Choban I. N.; Bersuker, I. B.; Kintya, P. K.; Balashova, N. N.; Bioorg. Khim, 11 (3), 408-413, 1985 discloses rockogenin .beta.-D-galactopyranoside and tigogenin .beta.-D-lactoside. "Preparation and Properties of Some New Steroid .beta.-D-Glucopyranosides, .beta.-D-Glucopyranosiduronic Acids, and Derivatives", Schneider, J. J.; Carb. Research, 17, 199-207, 1971 discloses tigogenin .beta.-D-glucopyranuronoside. "Sterol Glycoside with Activity as Prostaglandin Synthetase Inhibitor", Pegel, K. H. Walker, H.; U.S. Pat. No. 4,260,603, Apr. 7, 1981 discloses hecogenin .beta.-D-glucopyranoside. "Hemolytic Properties of Synthetic Glycosides", Segal, R.; Shud, F.; Milo-Goldzweig, I.; J. Pharm. Sci. , 67 (11) 1589-1592, 1978 discloses tigogenin .beta.-D-maltosside, tigogenin .beta.-L-fucopyranoside smilagenin .beta.-maltoside and tigogenin .alpha.-L-rhamnoside. "Steroid Glycosides from the Roots of Capsicum annuum II: The Structure of the Capsicosides", Gutsu, E. V.; Kintya, P
REFERENCES:
patent: 4260603 (1981-04-01), Pegel et al.
patent: 4265886 (1981-05-01), Pegel et al.
patent: 4461762 (1984-07-01), Malinow
patent: 4552868 (1985-11-01), Jarreau et al.
patent: 4584289 (1986-04-01), Jarreau et al.
patent: 4602003 (1986-07-01), Malinow
patent: 4602005 (1986-07-01), Malinow
patent: 4885280 (1989-12-01), Jarreau et al.
patent: 5010185 (1991-04-01), Urban
patent: 5017562 (1991-05-01), Holmes et al.
patent: 5530107 (1996-06-01), Douglas et al.
Freire et al. Chromatography in Biochemistry, Medicine and Environmental Research vol. 1 pp. 249-259, (1983).
Woo et al. J. Natl. Products, vol. 55(8), pp. 1129-1135, (1992). Abstract only.
Tsung et al. Hua Hsueh Hsueh Pao, vol. 34(3), pp. 179-196, (1976) Abstract Only.
Malinow, M. R. et al., Annals of the N.Y. Academy of Sciences, 454 (Atherosclerosis); 23-27, 1985.
Dimoglo et al., Chemical Abstracts, 103:66658x, 1985.
Sidhu et al., Chemical Abstracts, 107:22075h, 1987.
Nakano et al., Phytochemistry 30 (6), 1993-1995, 1991.
"Effects of Alpha-and Beta-Tigogenin Cellobiosides on Cholesterol Absorption" Malinow, M.R. et al.; Steroids Structure, Function, and Regulation; 48(3-4), 197-211; 1986.
"Determination of the Absolute Configuration of a Secondary Hydroxy Group in a Chiral Secondary Alcohol Using Glycosidation Shifts in Carbon-13 NMR Spectroscopy" Seo, S.; Tomita, Y.; Tori, K.; Yoshimura, Y.; J. Am. Chem. Soc. 100(11), 3331-3339, 1978.
"Glycosidation Shifts in Carbon-13 NMR Spectroscopy: Carbon-13 Signal Shifts from Aglycone and Glucose to Glucoside" Tori, K.; Yoshimura, Y.; Arita, H.; Tomita, Y.; Tetrahed. Lett. (2), 179-182, 1977.
"Chemistry of Ayurvedic Crude Drugs: Part VIII-Shatavari-2: Structure Elucidation of Bioactive Shatavarin-I and Other Glycosides" Joshi, J.; Dev, S.; Ind. J. Chem 27B, 12-16, 1988.
"Molluscicidal Saponins from Cornus Florida L." Hostettmann, K.; Hostettmann-Kaldas, M.; Nakanishi, K.; Helv. Chim. Acta 61, 1990-1995, 1978.
"Carbon-13 NMR Spectroscopy of Steroidal Sapogenins and Steroidal Saponins" Agrawal, P.K.; Jain, D.C.; Gupta, R.K. Thakur, R.S.; Phytochemistry 24 (11), 2479-2496, 1985.
"Studies on the Constituents of Asparagi Radix. I. On the Structures of Furostanol Oligosides of Asparagus Cochinchinensis Merrill" Konishi, T.; Shoji, J.; Chem. Pharm. Bull. 27 (12), 3086-3094, 1979.
"Saponins of the Spirostanol Series. XII. Parillin, A Saponin with a Highly Branched Sugar Chain" Tschesche, R.; Kottler, R.; Wulff, G.; Just. Liebigs Ann. Chem. 699, 212-222, 1966.
"Damaging Effects of Saponins on Termites" Tschesche, R.; Wulff, G.; Weber, A.; Schmidt, H.Z.; Naturforsch. B 25 (9) 999-1001, 1970.
"Medicinal Asparagus ( Asparagus Officinalis L.) as a Source of Steroidal Glycosides" Goryanu, G.M.; Krokhmalyuk, V.V.; Kintya, P.K.; Glyzin, V.I.; Farmatsiya (Moscow) 25 (4), 66-7, 1976.
"Two New Steroidal Glucuronides From Solanum Lyratum, II" Yahara, S.; Morooka, M.; Ikeda, M.; Yamasaki, M.; Nohara, T.; Planta Med. (6) 496-8, 1986.
"Preparation and properties of Some New Steroid Beta-D-Glucopyranosides, Beta-D-Glucopyranosiduronic Acids, and Derivatives" Schneider, J.; J. Carb. Research 17, 199-207, 1971.
"Structure Activity Relationships in Steroid Glycosides" Dimolgo, A.S.; Choban, I.N.; Bersuker, I.B.; Kintya, P.K.; Khim. Far., Zh. 19 (2), 185-9, 1985.
"Modifiers of Bilayer Lipid Membranes Among Steroid Glycosides" Bogatskii, A.V.; Nazarova, N. Yu.; Kintya, P.K.; Bobeiko, V.A.; Dokl. Akad. Nauk, SSSR (Biophys) 252 235-7, 1980.
"Steroidal Saponins from Several Species of Lilliflorae Plants" Yang, C.; Li, K.; Ding, Y.; Yunnan Zhiwu Yanjiu Zengkan, Suppl. 3, 13-23, 1990.
"Search for Hypocholesterolemic Agents Steroid Glycosides" Kintya, P.K.; Vasilenko, I.K.; Gorianu, G.M.; Bobeiko, V.A.; Suetina, I.V.; Mashchenko, N.E. Khim. Farm. Zh. 15 (9), 55-60, 1981. (Translation provided).
"Steroid Glycosides from the Leaves of Agave Americana" Lazurevskii, G.V.; Bobeiko, V.A.; Kintya, P.K.; Dokl. Akad. Nauk. SSSR 224 (6), 1442-1444, 1975. (Translation provided).
"Steroid Glycosi
DeNinno Michael P.
McCarthy Peter A.
Benson Gregg C.
Kight John
Lee Howard C.
Olson A. Dean
Pfizer Inc.
LandOfFree
Steroidal glycosides for treating hypercholesterolemia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Steroidal glycosides for treating hypercholesterolemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Steroidal glycosides for treating hypercholesterolemia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1385453